The correlation between plasma FEZF1-AS1 expression levels and clinicopathological features of age, gender, smoking status, histological classification, tumor size, lymph node status and metastasis, and clinical stages are summarized in Table 2. This evidence concerns the gene FEZF1 and neoplasm.